BRPI0700832B8 - composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína - Google Patents

composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Info

Publication number
BRPI0700832B8
BRPI0700832B8 BRPI0700832A BRPI0700832A BRPI0700832B8 BR PI0700832 B8 BRPI0700832 B8 BR PI0700832B8 BR PI0700832 A BRPI0700832 A BR PI0700832A BR PI0700832 A BRPI0700832 A BR PI0700832A BR PI0700832 B8 BRPI0700832 B8 BR PI0700832B8
Authority
BR
Brazil
Prior art keywords
prilocaine
lidocaine
suspension
anesthetic composition
topical anesthetic
Prior art date
Application number
BRPI0700832A
Other languages
English (en)
Inventor
Raffin Pohlmann Adriana
Alario Júnior Dante
Ronsoni Zancan Lali
Stanisçuaski Guterres Sílvia
Original Assignee
Biolab Sanus Farmaceutica Ltda
Univ Federal Do Rio Grande Do Sul Ufrgs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39765309&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0700832(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Biolab Sanus Farmaceutica Ltda, Univ Federal Do Rio Grande Do Sul Ufrgs filed Critical Biolab Sanus Farmaceutica Ltda
Priority to BRPI0700832A priority Critical patent/BRPI0700832B8/pt
Priority to JP2009553872A priority patent/JP5496684B2/ja
Priority to PT87145173T priority patent/PT2134334T/pt
Priority to EP08714517.3A priority patent/EP2134334B1/en
Priority to CL200800728A priority patent/CL2008000728A1/es
Priority to HUE08714517A priority patent/HUE051155T2/hu
Priority to ES08714517T priority patent/ES2804466T3/es
Priority to PCT/BR2008/000070 priority patent/WO2008113144A1/en
Priority to MX2009009853A priority patent/MX2009009853A/es
Priority to PL08714517T priority patent/PL2134334T3/pl
Priority to US12/531,404 priority patent/US8568788B2/en
Priority to ARP080101035A priority patent/AR065723A1/es
Priority to PE2008000474A priority patent/PE20081883A1/es
Priority to PE2013000512A priority patent/PE20131337A1/es
Publication of BRPI0700832A publication Critical patent/BRPI0700832A/pt
Priority to CO09114245A priority patent/CO6220944A2/es
Priority to EC2009009691A priority patent/ECSP099691A/es
Publication of BRPI0700832B1 publication Critical patent/BRPI0700832B1/pt
Publication of BRPI0700832B8 publication Critical patent/BRPI0700832B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

composição anestésica nanoparticulada para uso tópico. a presente invenção se refere a uma composição anestésica nanoparticulada para uso tópico em que pelo menos um agente anestésico local está encapsulado em nanopartículas poliméricas. a presente invenção também se refere ao uso de tais nanopartículas políméricas compreendendo pelo menos um agente anestésico local, na preparação de uma composição anestésica para aplicação tópica sobre a pele ou mucosas.
BRPI0700832A 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína BRPI0700832B8 (pt)

Priority Applications (16)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína
PT87145173T PT2134334T (pt) 2007-03-16 2008-03-12 Composição anestésica nanoparticulada para utilização tópica
MX2009009853A MX2009009853A (es) 2007-03-16 2008-03-12 Composicion anestesica nanoparticulada para la administracion topica.
US12/531,404 US8568788B2 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
EP08714517.3A EP2134334B1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
CL200800728A CL2008000728A1 (es) 2007-03-16 2008-03-12 Composicion anestesica para la administracion topica que comprende un agente anestesico local en nanoparticulas polimericas y por lo menos un agente que aumenta la viscosidad.
HUE08714517A HUE051155T2 (hu) 2007-03-16 2008-03-12 Nanorészecske formájú fájdalomcsillapító készítmény topikális alkalmazásra
ES08714517T ES2804466T3 (es) 2007-03-16 2008-03-12 Composición anestésica de uso tópico en forma de nanopartículas
PCT/BR2008/000070 WO2008113144A1 (en) 2007-03-16 2008-03-12 Nanoparticulated anesthetic composition for topic use
JP2009553872A JP5496684B2 (ja) 2007-03-16 2008-03-12 局所使用のためのナノ粒子状麻酔薬組成物
PL08714517T PL2134334T3 (pl) 2007-03-16 2008-03-12 Kompozycja znieczulająca w postaci nanocząstek do miejscowego stosowania
ARP080101035A AR065723A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2013000512A PE20131337A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
PE2008000474A PE20081883A1 (es) 2007-03-16 2008-03-13 Composicion anestesica nanoparticulada para la administracion topica
CO09114245A CO6220944A2 (es) 2007-03-16 2009-10-14 Composicion anestesica nanoparticulada para la administracion topica
EC2009009691A ECSP099691A (es) 2007-03-16 2009-10-14 Composición anestésica nanoparticulada para la administración tópica

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Publications (3)

Publication Number Publication Date
BRPI0700832A BRPI0700832A (pt) 2008-11-04
BRPI0700832B1 BRPI0700832B1 (pt) 2017-12-26
BRPI0700832B8 true BRPI0700832B8 (pt) 2021-05-25

Family

ID=39765309

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0700832A BRPI0700832B8 (pt) 2007-03-16 2007-03-16 composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína

Country Status (15)

Country Link
US (1) US8568788B2 (pt)
EP (1) EP2134334B1 (pt)
JP (1) JP5496684B2 (pt)
AR (1) AR065723A1 (pt)
BR (1) BRPI0700832B8 (pt)
CL (1) CL2008000728A1 (pt)
CO (1) CO6220944A2 (pt)
EC (1) ECSP099691A (pt)
ES (1) ES2804466T3 (pt)
HU (1) HUE051155T2 (pt)
MX (1) MX2009009853A (pt)
PE (2) PE20131337A1 (pt)
PL (1) PL2134334T3 (pt)
PT (1) PT2134334T (pt)
WO (1) WO2008113144A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142592B2 (en) 2008-10-02 2012-03-27 Mylan Inc. Method for making a multilayer adhesive laminate
BR102012022036B1 (pt) * 2012-08-31 2019-10-01 Biolab Sanus Farmacêutica Ltda. Nanopartícula polimérica de finasterida e minoxidil, processo de sua preparação, suspensão aquosa contendo a mesma, composição farmacêutica, e seu uso
BR102014028009B1 (pt) 2014-11-10 2023-04-18 Universidade Federal De Pelotas Composições filmogênicas para bioadesivos anestésicos tópicos (bats) para liberação controlada de princípios ativos e bioadesivos anestésicos tópicos
US11452700B2 (en) 2017-08-04 2022-09-27 Eric Haas Method of delivering an anesthetic agent and glucocorticoid micro and nano bioerodible particles
CN113244167B (zh) * 2021-05-20 2022-11-29 河北科技大学 一种盐酸利多卡因凝胶及其制备方法
RU208882U1 (ru) * 2021-08-25 2022-01-19 Федеральное государственное бюджетное образовательное учреждение высшего образования "Курская государственная сельскохозяйственная академия имени И.И. Иванова" Раневая атравматическая повязка для животных

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7713618L (sv) * 1977-12-01 1979-06-02 Astra Laekemedel Ab Lokalanestetisk blandning
FR2659554B1 (fr) * 1990-03-16 1994-09-30 Oreal Composition pour le traitement cosmetique et/ou pharmaceutique des couches superieures de l'epiderme par application topique sur la peau et procede de preparation correspondant.
DE4120760A1 (de) * 1991-06-24 1993-03-04 3 M Medica Gmbh Traegersysteme fuer arzneimittel
JPH09255565A (ja) * 1996-03-26 1997-09-30 Daikyo Yakuhin Kogyo Kk 皮膚局所麻酔用ヒドロゲルパッチ
IL129951A0 (en) * 1997-07-02 2000-02-29 Euro Celtique Sa Prolonged anesthesia in joints and body spaces
US5993836A (en) * 1998-04-28 1999-11-30 Castillo; James G. Topical anesthetic formulation
KR100463167B1 (ko) * 2001-04-13 2004-12-23 주식회사 태평양 고분자 나노입자를 이용한 경피흡수제 및 이를 함유한외용제 조성물
US20070154527A1 (en) * 2001-10-12 2007-07-05 Monosoirx, Llc Topical film compositions for delivery of actives
WO2006002365A2 (en) * 2004-06-24 2006-01-05 Angiotech International Ag Microparticles with high loadings of a bioactive agent
US8940311B2 (en) * 2004-10-21 2015-01-27 Tae-Hong Lim In situ controlled release drug delivery system
WO2006091719A2 (en) * 2005-02-23 2006-08-31 Sontra Medical Corporation Compositions and methods enhancing transdermal delivery of drugs and biologics

Also Published As

Publication number Publication date
EP2134334A4 (en) 2013-04-24
WO2008113144A1 (en) 2008-09-25
BRPI0700832A (pt) 2008-11-04
JP2010521498A (ja) 2010-06-24
EP2134334B1 (en) 2020-05-13
US20100086614A1 (en) 2010-04-08
MX2009009853A (es) 2010-02-18
AR065723A1 (es) 2009-06-24
US8568788B2 (en) 2013-10-29
PE20131337A1 (es) 2013-11-18
ES2804466T3 (es) 2021-02-08
BRPI0700832B1 (pt) 2017-12-26
ECSP099691A (es) 2010-02-26
PT2134334T (pt) 2020-08-20
CL2008000728A1 (es) 2008-09-26
PL2134334T3 (pl) 2021-03-08
HUE051155T2 (hu) 2021-03-01
JP5496684B2 (ja) 2014-05-21
EP2134334A1 (en) 2009-12-23
PE20081883A1 (es) 2008-12-27
CO6220944A2 (es) 2010-11-19

Similar Documents

Publication Publication Date Title
BRPI0700832B8 (pt) composição anestésica tópica compreendendo suspensão de nanocápsulas poliméricas de lidocaína e prilocaína
CL2017002549A1 (es) Uso de una composición de bismuto-tiol (bt), que sirve para preparar un medicamento útil para el tratamiento de una herida abierta que tiene o que está en riesgo de tener una infección de biopelícula bacteriana.
BRPI0921002A8 (pt) Composições para tratamento bucal compreendendo sílica fundida e seu uso
BRPI0921249A8 (pt) uso de matriz extracelular na preparação de uma composição,uso de matriz extracelular e agente quimioterápico na preparação de uma composição, e composições para o tratamento do cãncer
BRPI0910874B8 (pt) formulação tópica para uso no tratamento tópico de uma condição da pele que resulta da produção de espécies reativas de oxigênio e/ou para a promoção da cicatrização de ferida tópica na pele de um indivíduo e uso da referida formulação
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
BR112015019657A2 (pt) composições tópicas e métodos de uso das mesmas
BR112015010392A2 (pt) composição para tratamento de pele
BR112014016668A8 (pt) composições para cuidados pessoais contendo silicone iônico e agente formador de filme
BR112012010038A2 (pt) revestimentos microbicidas com microestrutura preferencial para dispositivos médicos
EA200970724A1 (ru) Композиции для местного применения, содержащие пероксид и ретиноид
HN2009000784A (es) Dihidropirazolonas sustituidas
BRPI0801858A2 (pt) uso de pelo menos um meio de cultura celular condicionado ou de seu extrato e composiÇço cosmÉtica ou dermatolàgica
WO2009063508A3 (en) Nanoparticle composition and process thereof
BRPI0815627A2 (pt) Material de revestimento, processo para a produção de um agente de revestimento, e, uso de um material de revestimento.
BRPI0621170B8 (pt) pó hesmostático, bandagem hesmostática para feridas e método de manufatura de um pó hesmostático
BRPI0809667A2 (pt) Composto, medicamento e composição farmacêutica que o contém e uso do composto
AR076825A1 (es) Composicion de lubricacion con coeficiente de friccion adaptable, para un elemento roscado de un componente de junta roscada tubular
BR112016013195A2 (pt) Composições para a higiene bucal compreendendo carbonato de cálcio e uma argila
UY31765A (es) Dihidropirazolonas sustituidas y su uso
CL2011003327A1 (es) Composicion farmaceutica que comprende finafloxacina y un agente antiinflamatorio; uso en el tratamiento de infecciones oftalmicas, oticas o nasales.
BR112014010457B8 (pt) processo para a fabricação de uma composição cosmética
BRPI1003281A2 (pt) Composição e método para maquilar um substrato queratínico
BR112012001240A2 (pt) dispersão polimérica aquosa, processo para preparar uma dispersão polimérica aquosa, agente de revestimento na forma de uma composição aquosa, e, uso da dispersão polimérica aquosa
BR112014001493A2 (pt) montante para uso na indústria de fundição, composição moldável para a produção de montantes para a indústria de fundição, processo para a preparação de uma composição moldável para a produção de montantes para a indústria de fundição e uso da cinza de casca de arroz

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B65X Notification of requirement for priority examination of patent application
B65Y Grant of priority examination of the patent application (request complies with dec. 132/06 of 20061117)
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 26/12/2017, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61K 9/51 (2006.01), A61P 23/02 (2006.01)

B16C Correction of notification of the grant

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 16/03/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF